Concepedia

Caroline Sychterz

CS

Statistics

Publications

7

Citations

300

H-Index

7

Active since

2011

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Caroline Sychterz is an author at GlaxoSmithKline (United States) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2023

7

Publications

7

Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer

Yanli Deng, Caroline Sychterz, A. Benjamin Suttle et al. · Xenobiotica · 2012 · 83 citations

Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF/PDGF RTK Inhibitors for Ocular Neovascular Disease

Scott Robbie, Peter Lundh von Leithner, Meihua Ju et al. · Investigative Ophthalmology & Visual Science · 2013 · 74 citations

Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model

Peter Adamson, Thomas Wilde, Eric Dobrzynski et al. · Journal of Controlled Release · 2016 · 58 citations · Full text

Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules

Andrew W. Harrell, Caroline Sychterz, May Y. K. Ho et al. · Pharmacology Research & Perspectives · 2015 · 32 citations · Full text

Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics

John F. Kellie, Kristen E. Pannullo, Yinghe Li et al. · Analytical Chemistry · 2020 · 21 citations

, , +18

1–5 of 7